Not known Factual Statements About cgmp compliance
No. 21 CFR 211.113(a) calls for suitable composed strategies being recognized and followed during manufacturing to avoid objectionable microorganisms in drug products not necessary to be sterile. Also, the next paragraph of USP Normal Chapter Antimicrobial Usefulness Screening reads: Antimicrobial preservatives really should not be used in